These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 17666446)

  • 1. The dual inhibitor of lipoxygenase and cyclooxygenase ML3000 decreases the expression of CXCR3 ligands.
    Ospelt C; Kurowska-Stolarska M; Neidhart M; Michel BA; Gay RE; Laufer S; Gay S
    Ann Rheum Dis; 2008 Apr; 67(4):524-9. PubMed ID: 17666446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic induction of CXCL9 and CXCL11 by Toll-like receptor ligands and interferon-gamma in fibroblasts correlates with elevated levels of CXCR3 ligands in septic arthritis synovial fluids.
    Proost P; Verpoest S; Van de Borne K; Schutyser E; Struyf S; Put W; Ronsse I; Grillet B; Opdenakker G; Van Damme J
    J Leukoc Biol; 2004 May; 75(5):777-84. PubMed ID: 14996826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The production of CXCR3-agonistic chemokines by synovial fibroblasts from patients with rheumatoid arthritis.
    Ueno A; Yamamura M; Iwahashi M; Okamoto A; Aita T; Ogawa N; Makino H
    Rheumatol Int; 2005 Jun; 25(5):361-7. PubMed ID: 15004722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual inhibition of 5-lipoxygenase and cyclooxygenases 1 and 2 by ML3000 reduces joint destruction in adjuvant arthritis.
    Gay RE; Neidhart M; Pataky F; Tries S; Laufer S; Gay S
    J Rheumatol; 2001 Sep; 28(9):2060-5. PubMed ID: 11550975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High CXCR3 expression in synovial mast cells associated with CXCL9 and CXCL10 expression in inflammatory synovial tissues of patients with rheumatoid arthritis.
    Ruschpler P; Lorenz P; Eichler W; Koczan D; Hänel C; Scholz R; Melzer C; Thiesen HJ; Stiehl P
    Arthritis Res Ther; 2003; 5(5):R241-52. PubMed ID: 12932287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression, regulation, and signaling of the pattern-recognition receptor nucleotide-binding oligomerization domain 2 in rheumatoid arthritis synovial fibroblasts.
    Ospelt C; Brentano F; Jüngel A; Rengel Y; Kolling C; Michel BA; Gay RE; Gay S
    Arthritis Rheum; 2009 Feb; 60(2):355-63. PubMed ID: 19180502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of overexpression of CXCL10 (cytokine-responsive gene-2) on MA-10 mouse Leydig tumor cell steroidogenesis and proliferation.
    Nagpal ML; Chen Y; Lin T
    J Endocrinol; 2004 Dec; 183(3):585-94. PubMed ID: 15590984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression profile analysis of rheumatoid synovial fibroblast cultures revealing the overexpression of genes responsible for tumor-like growth of rheumatoid synovium.
    Watanabe N; Ando K; Yoshida S; Inuzuka S; Kobayashi M; Matsui N; Okamoto T
    Biochem Biophys Res Commun; 2002 Jun; 294(5):1121-9. PubMed ID: 12074593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coexpression and interaction of CXCL10 and CD26 in mesenchymal cells by synergising inflammatory cytokines: CXCL8 and CXCL10 are discriminative markers for autoimmune arthropathies.
    Proost P; Struyf S; Loos T; Gouwy M; Schutyser E; Conings R; Ronsse I; Parmentier M; Grillet B; Opdenakker G; Balzarini J; Van Damme J
    Arthritis Res Ther; 2006; 8(4):R107. PubMed ID: 16846531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adiponectin inhibits the production of CXC receptor 3 chemokine ligands in macrophages and reduces T-lymphocyte recruitment in atherogenesis.
    Okamoto Y; Folco EJ; Minami M; Wara AK; Feinberg MW; Sukhova GK; Colvin RA; Kihara S; Funahashi T; Luster AD; Libby P
    Circ Res; 2008 Feb; 102(2):218-25. PubMed ID: 17991878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trex-1 deficiency in rheumatoid arthritis synovial fibroblasts.
    Neidhart M; Karouzakis E; Schumann GG; Gay RE; Gay S
    Arthritis Rheum; 2010 Sep; 62(9):2673-9. PubMed ID: 20496420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CXCR3/CXCL10 expression in the synovium of children with juvenile idiopathic arthritis.
    Martini G; Zulian F; Calabrese F; Bortoli M; Facco M; Cabrelle A; Valente M; Zacchello F; Agostini C
    Arthritis Res Ther; 2005; 7(2):R241-9. PubMed ID: 15743470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological characterization of CXC chemokine receptor 3 ligands and a small molecule antagonist.
    Heise CE; Pahuja A; Hudson SC; Mistry MS; Putnam AL; Gross MM; Gottlieb PA; Wade WS; Kiankarimi M; Schwarz D; Crowe P; Zlotnik A; Alleva DG
    J Pharmacol Exp Ther; 2005 Jun; 313(3):1263-71. PubMed ID: 15761110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of CCL13 expression in synovial fibroblasts highlights a significant role of oncostatin M in rheumatoid arthritis.
    Hintzen C; Quaiser S; Pap T; Heinrich PC; Hermanns HM
    Arthritis Rheum; 2009 Jul; 60(7):1932-43. PubMed ID: 19565514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abundant expression of the interleukin (IL)23 subunit p19, but low levels of bioactive IL23 in the rheumatoid synovium: differential expression and Toll-like receptor-(TLR) dependent regulation of the IL23 subunits, p19 and p40, in rheumatoid arthritis.
    Brentano F; Ospelt C; Stanczyk J; Gay RE; Gay S; Kyburz D
    Ann Rheum Dis; 2009 Jan; 68(1):143-50. PubMed ID: 18276743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin induces apoptosis and inhibits prostaglandin E(2) production in synovial fibroblasts of patients with rheumatoid arthritis.
    Park C; Moon DO; Choi IW; Choi BT; Nam TJ; Rhu CH; Kwon TK; Lee WH; Kim GY; Choi YH
    Int J Mol Med; 2007 Sep; 20(3):365-72. PubMed ID: 17671742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of RNAi on cyclooxygenase-2 expression and biologic activity of human rheumatoid arthritis synovial fibroblasts].
    Jiang LD; Wang HZ; Zhao FD; Guo JS; Bao CD; Zou HJ; Wang JY
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(41):2925-8. PubMed ID: 18261308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a novel tyrosine kinase inhibitor in rheumatoid arthritis synovial fibroblasts.
    Huber LC; Künzler P; Boyce SH; Michel BA; Gay RE; Ink BS; Gay S
    Ann Rheum Dis; 2008 Mar; 67(3):389-94. PubMed ID: 17660218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modelling of the membrane receptor CXCR3 and its complexes with CXCL9, CXCL10 and CXCL11 chemokines: putative target for new drug design.
    Trotta T; Costantini S; Colonna G
    Mol Immunol; 2009 Dec; 47(2-3):332-9. PubMed ID: 19800124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of toll-like receptors 3 and 4 in synovial tissue from patients with early rheumatoid arthritis: toll-like receptor expression in early and longstanding arthritis.
    Ospelt C; Brentano F; Rengel Y; Stanczyk J; Kolling C; Tak PP; Gay RE; Gay S; Kyburz D
    Arthritis Rheum; 2008 Dec; 58(12):3684-92. PubMed ID: 19035519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.